T1	intervention 23 27	yoga
T2	condition 31 72	chemotherapy-related cognitive impairment
T3	No-of-participants 769 773	Four
T4	eligibility 774 857	women with a diagnosis of early-stage breast cancer prior to chemotherapy treatment
T5	outcome-Measure 1166 1175	cognition
T6	duration 1359 1367	12 weeks
T7	average-age 1574 1585	44-65 years
T8	No-of-participants 1516 1520	Four
T9	outcome 1624 1663	changes in varying domains of cognition
T10	outcome 1697 1735	Improved balance, flexibility, and QOL
T11	outcome 1763 1780	No adverse events
